To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Aryl hydrocarbon receptor nuclear translocator-like 2 (ARNTL2; BMAL2)

Cancer

INDICATION: Lung cancer

Patient sample, cell culture and mouse studies suggest inhibiting ARNTL2 could help

Read the full 143 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE